Characteristics and prognosis of patients with Edwardsiella tarda bacteremia at a single institution, Japan, 2005–2022

Table 3 Antibiotic susceptibility of 38 Edwardsiella tarda strains from blood culture

Antibiotics	MIC value (μg/mL)									Susceptible (%)	Intermediate (%)	Resistant (%)
Antibiotics	≤ 0.5	1.0	2	4	8	16	16 <	2/38	64 <	Susceptible (%)	Intermediate (%)	Resistant (%)
Ampicillin				11*	26**		1			97.4	0	2.6
Piperacillin					37***				1	97.4	0	2.6
Ampicillin-Sulbactam⁺					27*					100	0	0
Piperacillin-Tazobactam⁺						27*				100	0	0
Cefazolin				38***						100	0	0
Cefotaxime		11**			27*					100	0	0
Cefepime⁺			27*							100	0	0
Cefmetazole				11*	27**					100	0	0
Imipenem		38***								100	0	0
Meropenem⁺		27*								100	0	0
Aztreonam				27**	11*					100	0	0
Gentamicin		10**	28*							100	0	0
Levofloxacin	27*	11**								100	0	0
Minocycline		11**	27*							100	0	0
Trimethoprim-Sulfamethoxazole								38***		100	0	0

MIC minimum inhibitory concentration
*Lowest MIC including inequality that could be measured on the susceptibility panel after January 4, 2014
**Lowest MIC including inequality that could be measured on the susceptibility panel until January 3, 2014
***Lowest MIC including inequality that could be measured on the susceptibility panel through the study period
⁺Antibiotics that were started to measure MIC after January 4, 2014

ISSN: 1476-0711